Company research
SOLESENCE, INC.
CIK 883107Updated Sep 27, 2026
SecuritySLSN · NASDAQ · equity
Historical securities (1)
NANX · OTC · equity · closed Apr 7, 2025Name history
NANOPHASE TECHNOLOGIES Corp · through Mar 31, 2025NANOPHASE TECHNOLOGIES CORPORATION · through Feb 1, 2016
SLSN price & chart
Loading TradingView…
NASDAQ:SLSN on TradingView ↗In the news
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11 ↗
Recent filings
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report
Items 4.02, 9.01
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
NT 10-Q filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 50,055,000Source | 50,002,000Source | 32,881,000Source | 33,558,000Source |
| Property, Plant and Equipment, NetUSD | 14,329,000Source | 12,734,000Source | 8,668,000Source | 7,949,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,288,000Source | 1,409,000Source | 1,722,000Source | 2,186,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,836,000Source | 4,869,000Source | 3,467,000Source | 4,734,000Source |
| Inventory, NetUSD | 18,511,000Source | 20,267,000Source | 10,031,000Source | 8,839,000Source |
| Assets, CurrentUSD | 28,776,000Source | 29,348,000Source | 16,302,000Source | 16,625,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,141,000Source | 2,803,000Source | 1,082,000Source | 866,000Source |
| Operating Lease, Right-of-Use AssetUSD | 6,913,000Source | 7,917,000Source | 7,907,000Source | 8,978,000Source |
| Other Assets, NoncurrentUSD | 37,000Source | 3,000Source | 4,000Source | 6,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 706,000Source | 700,000Source | 496,000Source | 493,000Source |
| Additional Paid in CapitalUSD | 115,566,000Source | 114,674,000Source | 106,069,000Source | 105,226,000Source |
| Retained Earnings (Accumulated Deficit)USD | -98,638,000Source | -100,428,000Source | -104,663,000Source | -100,070,000Source |
| Stockholders' Equity Attributable to ParentUSD | 17,634,000Source | 14,946,000Source | 1,902,000Source | 5,649,000Source |
| Liabilities and EquityUSD | 50,055,000Source | 50,002,000Source | 32,881,000Source | 33,558,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 13,929,000Source | 25,773,000Source | 15,589,000Source | 16,835,000Source |
| Operating Lease, Liability, CurrentUSD | 1,255,000Source | 1,260,000Source | 1,297,000Source | 0Source |
| Accounts Payable, CurrentUSD | 4,098,000Source | 9,093,000Source | 6,260,000Source | 6,363,000Source |
| Operating Lease, Liability, NoncurrentUSD | 7,798,000Source | 9,037,000Source | 9,152,000Source | 9,823,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 2,879,000Source | 4,849,000Source | 869,000Source | 1,023,000Source |
| Deferred Revenue, CurrentUSD | 930,000Source | 5,571,000Source | 2,353,000Source | 2,167,000Source |
| Deferred Revenue, NoncurrentUSD | — | — | — | 21,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | 1,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 897,000Source | 928,000Source | 742,000Source | 567,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 575,000Source | 725,000Source | 773,000Source | 625,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,967,000Source | 1,402,000Source | -1,064,000Source | 797,000Source |
| Increase (Decrease) in InventoriesUSD | -1,756,000Source | 10,236,000Source | 1,192,000Source | 2,744,000Source |
| Increase (Decrease) in Accounts PayableUSD | -5,377,000Source | 2,399,000Source | -503,000Source | 1,826,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -8,567,000Source | 1,971,000Source | -2,006,000Source | -1,650,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,143,000Source | -4,558,000Source | -1,051,000Source | -2,823,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 4,558,000Source | 1,051,000Source | 2,823,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 10,589,000Source | 2,274,000Source | 2,593,000Source | 6,002,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -121,000Source | -313,000Source | -464,000Source | 1,529,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,288,000Source | 1,409,000Source | 1,722,000Source | 2,186,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,022,000Source | 637,000Source | 752,000Source | 333,000Source |
| Additional Financial Items | ||||
| Asset Retirement Obligation, Accretion ExpenseUSD | 8,000Source | — | 8,000Source | 8,000Source |
| DepreciationUSD | 888,000Source | 918,000Source | 732,000Source | 557,000Source |
| Income Tax Expense (Benefit)USD | 73,000Source | 227,000Source | 6,000Source | -17,000Source |
| InterestExpenseNonoperatingUSD | — | 670,000Source | — | — |
| Investment Income, InterestUSD | 194,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | 1,790,000Source | 4,235,000Source | -4,390,000Source | -2,623,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 2,053,000Source |
| Proceeds from Issuance of Common StockUSD | 323,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | — | 2,084,000Source | 73,000Source | 182,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 62,064,000Source | 52,347,000Source | 37,297,000Source | 37,317,000Source |
| Cost of RevenueUSD | 46,001,000Source | 36,159,000Source | 29,472,000Source | 28,957,000Source |
| Selling, General and Administrative ExpenseUSD | 10,401,000Source | 7,219,000Source | 7,534,000Source | 7,581,000Source |
| Operating Income (Loss)USD | 1,572,000Source | 5,132,000Source | -3,546,000Source | -2,258,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 1,863,000Source | 4,462,000Source | -4,384,000Source | -2,640,000Source |
| Income Tax Expense (Benefit)USD | 73,000Source | 227,000Source | 6,000Source | -17,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,790,000Source | 4,235,000Source | -4,390,000Source | -2,623,000Source |
| Earnings Per Share, BasicUSD per share | 0.03Source | 0.07Source | -0.09Source | -0.05Source |
| Earnings Per Share, DilutedUSD per share | 0.02Source | 0.07Source | -0.09Source | -0.05Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 70,344,152Source | 62,350,459Source | 49,556,305Source | 49,117,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 72,579,715Source | 65,028,815Source | 49,556,305Source | 49,117,000Source |
| Interest Expense (non-operating)USD | — | 670,000Source | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 60,274,000Source | 48,112,000Source | — | — |
| Gross ProfitUSD | 16,063,000Source | 16,188,000Source | 7,825,000Source | 8,360,000Source |
| Interest ExpenseUSD | — | — | 838,000Source | 382,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -931,000Source | — | — | — |
| Investment Income, InterestUSD | 194,000Source | — | — | — |
| Operating Lease, ExpenseUSD | — | — | — | 2,053,000Source |
| Research and Development ExpenseUSD | 4,090,000Source | 3,837,000Source | 3,837,000Source | 3,037,000Source |
Filing attachments
ex99-1.htm · 8-K · 2025-09-04
EX-99.1 5 ex99-1.htm PRESS RELEASE Solésence, Inc. 8-K Exhibit 99.1 Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth Strategic transformation of Solésence continues with Kevin Cureton promoted to President and Chief Executive Officer; Laura Riffner named Chief Financial Officer; Jess Jankowski to serve as Board Advisor Romeoville, Ill., September 3, 2025 - Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across b…
Read attachment ↗ex99-1.htm · 8-K · 2025-06-02
EX-99.1 5 ex99-1.htm PRESS RELEASE DATED JUNE 2, 2025 Solesence, Inc. 8-K Exhibit 99.1 Solésence Expands Debt Facilities to Fuel Growth Initiatives Romeoville, Ill., June 2, 2025 - Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objecti…
Read attachment ↗